83 related articles for article (PubMed ID: 2170226)
1. [Extent of psammoma carcinomas of the ovary--a clinical, DNA flow cytophotometric and morphometric image analysis study].
Kühn W; Feichter GE; Beier K; Rummel HH; Abel U; Kaufmann M
Geburtshilfe Frauenheilkd; 1990 Aug; 50(8):597-604. PubMed ID: 2170226
[TBL] [Abstract][Full Text] [Related]
2. DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumors.
Kühn W; Kaufmann M; Feichter GE; Rummel HH; Schmid H; Heberling D
Gynecol Oncol; 1989 Jun; 33(3):360-7. PubMed ID: 2722063
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic significance of flow cytophotometric studies in ovarian cancer].
Volm M; Kleine W
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):456-9. PubMed ID: 3623048
[TBL] [Abstract][Full Text] [Related]
4. [Serous borderline ovarian tumors].
Zipprich K; Albrecht G; Canzler E
Zentralbl Gynakol; 1985; 107(3):159-68. PubMed ID: 3984570
[TBL] [Abstract][Full Text] [Related]
5. [Image analysis of DNA cytometry for assessing prognosis after resection of esophageal cancer].
Böttger T; Störkel S; Stöckle M; Wahl W; Heintz A; Jugenheimer M; Effenberger-Kim O; Vinh T; Junginger T
Chirurg; 1991 Jun; 62(6):467-72; discussion 472-3. PubMed ID: 1655366
[TBL] [Abstract][Full Text] [Related]
6. [Relation between DNA content in ovarian cystadenoma and its pathohistology].
Sun ZC
Zhonghua Fu Chan Ke Za Zhi; 1993 Dec; 28(12):731-3, 760-1. PubMed ID: 8137645
[TBL] [Abstract][Full Text] [Related]
7. Computerized image analysis and flow cytometric evaluation of ovarian borderline tumors: a study of 24 cases.
Esposito MJ; Fuchs A
Cytometry; 1994 Dec; 18(4):218-22. PubMed ID: 7895528
[TBL] [Abstract][Full Text] [Related]
8. Quantitative DNA analysis in breast carcinomas: a comparison between image analysis and flow cytometry.
Lee AK; Dugan J; Hamilton WM; Cook L; Heatley G; Kamat B; Silverman ML
Mod Pathol; 1991 Mar; 4(2):178-82. PubMed ID: 2047381
[TBL] [Abstract][Full Text] [Related]
9. [Clinical aspects and prognosis of granulosa cell tumors of the ovary].
Scharl A; Vierbuchen M; Kusche M; Bolte A
Geburtshilfe Frauenheilkd; 1988 Aug; 48(8):567-73. PubMed ID: 3215451
[TBL] [Abstract][Full Text] [Related]
10. Interphase cytogenetic analysis of serous ovarian tumors of low malignant potential: comparison with serous cystadenomas and invasive serous carcinomas.
Diebold J; Deisenhofer I; Baretton GB; Blasenbreu S; Suchy B; Schneiderbanger K; Meier W; Haas CJ; Löhrs U
Lab Invest; 1996 Oct; 75(4):473-85. PubMed ID: 8874380
[TBL] [Abstract][Full Text] [Related]
11. [Clinical course of ovarian cancer in relation to morphologic prognostic factors and cell kinetic parameters].
Kühn W; Feichter GE; Hanke J; Rummel HH; Kaufmann M; Schmid H
Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):446-51. PubMed ID: 3623047
[TBL] [Abstract][Full Text] [Related]
12. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
Meyer JS; Gersell DJ; Yim S
Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
[TBL] [Abstract][Full Text] [Related]
13. [Flow cytometry in the evaluation of the prognosis and course of malignant soft-tissue tumors].
Zubrikhina GN; Ol'khovskaia IG
Arkh Patol; 1990; 52(9):29-33. PubMed ID: 2270977
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of DNA content in epithelial ovarian cancer.
Gajewski WH; Fuller AF; Pastel-Ley C; Flotte TJ; Bell DA
Gynecol Oncol; 1994 Apr; 53(1):5-12. PubMed ID: 8175021
[TBL] [Abstract][Full Text] [Related]
15. Prediction of relapse in patients with breast cancer by DNA cytometry.
Machado-Santelli GM; Mori L; Pereira CA
Anal Cell Pathol; 1994 Dec; 7(4):321-34. PubMed ID: 7696156
[TBL] [Abstract][Full Text] [Related]
16. Quantitative measurement of DNA content in gastric carcinoma; flow cytometry and video image analysis.
Brito MJ; Rosa JC; Thomas VA; Filipe MI
Anal Cell Pathol; 1994 Jul; 7(1):1-9. PubMed ID: 7981132
[TBL] [Abstract][Full Text] [Related]
17. Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours.
Tan Y; Sinniah R; Bay BH; Singh G
J Pathol; 1999 Sep; 189(1):60-5. PubMed ID: 10451489
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of nuclear DNA content in pancreatic carcinoma.
Alanen KA; Joensuu H; Klemi PJ; Nevalainen TJ
J Pathol; 1990 Apr; 160(4):313-20. PubMed ID: 2358969
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of DNA content and S-phase fraction in epithelial ovarian carcinomas analyzed by image cytometry.
Reles AE; Gee C; Schellschmidt I; Schmider A; Unger M; Friedmann W; Lichtenegger W; Press MF
Gynecol Oncol; 1998 Oct; 71(1):3-13. PubMed ID: 9784312
[TBL] [Abstract][Full Text] [Related]
20. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
